Heart drug failure forces experts to rethink inflammation's role in disease

A promising heart drug designed to target inflammation has unexpectedly failed in clinical trials, delivering a major blow to cardiology. The failure challenges the long-held theory that inflammation is a direct cause of heart disease. Experts say the results force a fundamental rethink of preventive cardiology.

Similar stories

🏥 Health Promising heart drug fails in trial — experts question inflammation theory of heart disease NYT Health · 11h ago 🏥 Health Novo Nordisk's anti-inflammation drug fails heart disease trial — shares drop 7% STAT News · 6d ago 🏥 Health FDA approves enlicitide — a daily pill that lowers dangerous cholesterol without injections Vox · 12d ago